Andere Kunden interessierten sich auch für
![Human Apolipoprotein Mutants III]( "Human Apolipoprotein Mutants III")
Human Apolipoprotein Mutants III77,99 €![The Challenge of CMC Regulatory Compliance for Biopharmaceuticals]( "The Challenge of CMC Regulatory Compliance for Biopharmaceuticals")
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals154,99 €![The Challenge of CMC Regulatory Compliance for Biopharmaceuticals]( "The Challenge of CMC Regulatory Compliance for Biopharmaceuticals")
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals117,99 €![The Challenge of CMC Regulatory Compliance for Biopharmaceuticals]( "The Challenge of CMC Regulatory Compliance for Biopharmaceuticals")
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals154,99 €![Advanced Methods of Pharmacokinetic and Pharmacodynamic Systems Analysis]( "Advanced Methods of Pharmacokinetic and Pharmacodynamic Systems Analysis")
Advanced Methods of Pharmacokinetic and Pharmacodynamic Systems Analysis116,99 €![Principles and Treatment of Lipoprotein Disorders]( "Principles and Treatment of Lipoprotein Disorders")
Principles and Treatment of Lipoprotein Disorders74,99 €![Fortschritte der Chemie Organischer Naturstoffe / Progress in the Chemistry of Organic Natural Products]( "Fortschritte der Chemie Organischer Naturstoffe / Progress in the Chemistry of Organic Natural Products")
Fortschritte der Chemie Organischer Naturstoffe / Progress in the Chemistry of Organic Natural Products79,99 €
Adi Haber's thesis summarises the use of a new entity, the corrole, to combat one of the major cardiovascular diseases, atherosclerosis. She examines the effects of three rationally designed corrole-metal complexes on some of the many variables which contribute to the development of atherosclerosis. There is a focus on both the "bad" and "good" cholesterol carriers, LDL and HDL. Adi Haber proceeds from basic findings in pure chemistry through biochemical and cell culture tests to in vivo examinations. The work in this thesis shows that corroles are highly efficient both for early and late treatment of atherosclerosis in animals. These results will pave the way for ongoing regulated preclinical studies focussed on the development of metallocorroles as potential drugs for treating cardiovascular diseases.